Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAPLEURALStandard

TALC

TALC

Standard Dose
5GM/BOT
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TALC is listed in Drugs@FDA under application 021388 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TALC Form and strength POWDER;INTRAPLEURAL - 5GM/BOT Sponsor SCIARRA LABS Submission history Latest submission status date: 2014-06-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview TALC is listed in Drugs@FDA under application 021388 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TALC Form and strength POWDER;INTRAPLEURAL - 5GM/BOT Sponsor SCIARRA LABS Submission history Latest submission status date: 2014-06-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.